Letter to the editor

P Sesma; E Ameneiros-Lago

doi:10.4414/smw.2011.13302

Technical comment

Vol. 141 No. 4748 (2011)

Letter to the editor

P Sesma
E Ameneiros-Lago

DOI: https://doi.org/10.4414/smw.2011.13302
Cite this as:: Swiss Med Wkly. 2011;141:w13302
Published: 21.11.2011

References

Kesten F, Aschwanden M, Gubser P, Glatz K, Daikeler T, Hess C. Giant cell arteritis. Swiss Med Wkly. 2011;141:w13272 http://www.smw.ch/content/smw-2011-13272/.
Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol. 2011;23(1):43–9.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology. 1997;91(2):197–203.
Samardzic T, Jankovic V, Stosic-Grujicic S, Popadic D, Trajkovic V. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18. Clin Exp Immunol. 2001;124(2):274–81.
Dukas LC, Schacht E, Mazor Z, Stähelin HB. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int. 2005;16(3):332–8.
Schacht E. Osteoporosis in rheumatoid arthritis – significance of alfacalcidol in prevention and therapy. Z Rheumatol. 2000;59(Suppl 1):10–20.
Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev. 2011;10(3):155–62.
Fernández-Fernández FJ. Might pentoxifylline have a role as adjuvant therapy for patients with giant cell arteritis? Drugs Aging. 2011;28(19):847.
Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest. 1997;99(12):2842–50.
Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54(10):3310–8.

How to Cite

1.

Sesma P, Ameneiros-Lago E. Letter to the editor. Swiss Med Wkly [Internet]. 2011 Nov. 21 [cited 2024 Nov. 24];141(4748):w13302. Available from: https://smw.ch/index.php/smw/article/view/1383

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

[1] Kesten F, Aschwanden M, Gubser P, Glatz K, Daikeler T, Hess C. Giant cell arteritis. Swiss Med Wkly. 2011;141:w13272 http://www.smw.ch/content/smw-2011-13272/.

[2] Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol. 2011;23(1):43–9.

[3] Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology. 1997;91(2):197–203.

[4] Samardzic T, Jankovic V, Stosic-Grujicic S, Popadic D, Trajkovic V. Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18. Clin Exp Immunol. 2001;124(2):274–81.

[5] Dukas LC, Schacht E, Mazor Z, Stähelin HB. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min. Osteoporos Int. 2005;16(3):332–8.

[6] Schacht E. Osteoporosis in rheumatoid arthritis – significance of alfacalcidol in prevention and therapy. Z Rheumatol. 2000;59(Suppl 1):10–20.

[7] Zold E, Szodoray P, Nakken B, Barath S, Kappelmayer J, Csathy L, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev. 2011;10(3):155–62.

[8] Fernández-Fernández FJ. Might pentoxifylline have a role as adjuvant therapy for patients with giant cell arteritis? Drugs Aging. 2011;28(19):847.

[9] Brack A, Rittner HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest. 1997;99(12):2842–50.

[10] Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, et al. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum. 2006;54(10):3310–8.